Download this slideset for a multidisciplinary expert–curated overview of stage III NSCLC, including insights on staging and standard-of-care chemoradiation strategies as well as an update on contemporary radiation techniques.
Download this slideset to review the latest clinical data supporting the optimal use of checkpoint inhibitor therapy in patients with stage III NSCLC, including expert guidance on management of immunotherapy-related pulmonary toxicity.
Download this slideset to gain insights from our multidisciplinary panel of experts on the optimal use of concurrent chemoradiation and checkpoint inhibition in the treatment of a series of case patients with stage III NSCLC.
In this CME/MOC-certified, on-demand Webcast of a CCO symposium at CHEST 2019, a multidisciplinary panel of expert faculty, including a medical oncologist, a radiation oncologist, and a pulmonologist, review and discuss the latest data on optimal integration of immune checkpoint inhibitors into the care of patients with stage III NSCLC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.